The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association between remote monitoring and acute care visits in high-risk patients initiating intravenous antineoplastic therapy.
 
Robert Michael Daly
Leadership - Quadrant Holdings
Stock and Other Ownership Interests - Baxter (I); Cigna (I); CVS Health; IBM; Lilly (I); Pfizer (I); Quadrant Holdings (I); Walgreens Boots Alliance; Zoetis (I)
Other Relationship - AstraZeneca
 
Kevin Nicholas
No Relationships to Disclose
 
Jessica Flynn
No Relationships to Disclose
 
Katherine Panageas
Stock and Other Ownership Interests - AstraZeneca; Pfizer; Pfizer; Sunesis Pharmaceuticals
 
Nicholas Silva
No Relationships to Disclose
 
Elaine Duck
No Relationships to Disclose
 
Alice Zervoudakis
No Relationships to Disclose
 
Jessie C. Holland
No Relationships to Disclose
 
Rori Salvaggio
No Relationships to Disclose
 
Aaron Begue
No Relationships to Disclose
 
Isaac Wagner
Consulting or Advisory Role - Nan Fung Life Sciences
 
Stefania Sokolowski
No Relationships to Disclose
 
Melissa Zablocki
No Relationships to Disclose
 
Yeneat Ophelia Chiu
No Relationships to Disclose
 
Gilad Kuperman
No Relationships to Disclose
 
Brett A. Simon
Patents, Royalties, Other Intellectual Property - patent application US13/118109; patent application US2015/0290418
 
Wendy Perchick
No Relationships to Disclose
 
Diane Lauren Reidy
Honoraria - Novartis
Consulting or Advisory Role - Advanced Accelerator Applications; Chiasma; ITM Oncologics; Lexicon
Research Funding - Ipsen; Merck; Novartis